GlassScriptPhysician profile
Kaitlin Moore
NPI 1295158103
$5,567.80
in general payments reported to CMS, 2019-2025
25 companies · $891 in 2025
The $891 reported for 2025 was more than what 78% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,385 · 2022: $731 · 2023: $1,485 · 2024: $1,076 · 2025: $891.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,452.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $875.15 | 2021-2025 | Merlin@Home, Gallant, Assurity |
| Janssen Pharmaceuticals, INC | $849.10 | 2021-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $552.80 | 2022-2025 | Verquvo |
| Novartis Pharmaceuticals Corporation | $490.18 | 2021-2025 | |
| Boston Scientific Corporation | $417.79 | 2021-2024 | Watchman Flx, Watchman Access System, Emblem Mri S-Icd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $387.85 | 2021-2025 | Lifevest |
| Pfizer INC. | $342.35 | 2021-2025 | |
| Amgen INC. | $301.26 | 2021-2025 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $221.71 | 2022-2025 | Camzyos, Eliquis |
| Heartflow, INC. | $165.84 | 2022-2025 | Ffrct |
| Novo Nordisk INC | $157.98 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Bridgebio Pharma, INC. | $128.57 | 2025 | Attruby |
| Abiomed | $96.75 | 2024 | Impella |
| Itamar Medical INC | $88.81 | 2023-2024 | Watchpatone |
| Boehringer Ingelheim Pharmaceuticals, INC. | $77.82 | 2024-2025 | Jardiance |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $74.34 | 2021-2022 | |
| Scpharmaceuticals INC. | $58.55 | 2023-2024 | |
| Amarin Pharma, INC. | $56.85 | 2021-2022 | |
| Irhythm Technologies, INC. | $49.50 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Philips North America LLC | $46.42 | 2022-2024 | (Ck4) Mcot |
| Impulse Dynamics (USA) INC. | $33.88 | 2025 | Optimizer |
| Angiodynamics, INC. | $30.42 | 2021 | |
| Medicomp INC | $26.22 | 2023 | Telepatch Cardiac Monitor |
| Esperion Therapeutics, INC. | $19.98 | 2021 | |
| Chiesi USA, INC. | $17.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaitlin Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.